Pipeline Review on CSL Limited- Product Industry 2014

1
CSL Limited - Product Pipeline Review 2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published January 2014
• Single User PDF US 1500
• Corporate User PDF US 4500

2
CSL Limited - Product Pipeline Review 2014

• CSL Limited Product Pipeline Review 2014 provides
  data on the CSL Limited's research and
  development focus. The report includes
  information on current developmental pipeline,
  complete with latest updates, and features on
  discontinued and dormant projects.
• This report is built using data and information
  sourced from proprietary databases, CSL Limited's
  corporate website, SEC filings, investor
  presentations and featured press releases, both
  from CSL Limited and industry-specific third
  party sources.
• Inquiry Before Buying on this Report _at_
  http//www.reportsnreports.com/contacts/inquirybef
  orebuy.aspx?name274869.
• Scope
• CSL Limited Brief CSL Limited overview including
  business description, key information and facts,
  and its locations and subsidiaries.
• Review of current pipeline of CSL Limited human
  therapeutic division.
• Overview of pipeline therapeutics across various
  therapy areas.
• Coverage of current pipeline molecules in various
  stages of drug development, including the
  combination treatment modalities, across the
  globe.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
CSL Limited - Product Pipeline Review 2014

• Product profiles for late stage and clinical
  stage products of CSL Limited with complete
  description of the product's developmental
  history, mechanism of action, therapeutic class,
  target and major milestones.
• Recent updates of the CSL Limited's pipeline in
  the last quarter.
• Key discontinued and dormant projects.
• Latest news and deals relating to the products.
• Inquire for Discount _at_ http//www.reportsnreports.
  com/contacts/discount.aspx?name274869.
• Reasons to buy
• Evaluate CSL Limited's strategic position with
  total access to detailed information on its
  product pipeline.
• Assess the growth potential of CSL Limited in its
  therapy areas of focus.
• Identify new drug targets and therapeutic classes
  in the CSL Limited's RD portfolio and develop
  key strategic initiatives to reinforce pipeline
  in those areas.
• Exploit in-licensing opportunities by identifying
  windows of opportunity to fill portfolio gaps.
• Exploit collaboration and partnership
  opportunities with CSL Limited.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
CSL Limited - Product Pipeline Review 2014

• Avoid Intellectual Property Rights related
  issues.
• Explore the dormant and discontinued projects of
  CSL Limited and identify potential opportunities
  in those areas.
• List of Tables
• CSL Limited, Key Information 6CSL Limited, Key
  Facts 6CSL Limited - Pipeline by Indication,
  2014 9CSL Limited - Pipeline by Stage of
  Development, 2014 10CSL Limited - Monotherapy
  Products in Pipeline, 2014 11CSL Limited -
  Partnered Products in Pipeline, 2014 12CSL
  Limited - Partnered Products/ Combination
  Treatment Modalities, 2014 13CSL Limited -
  Out-Licensed Products in Pipeline, 2014 14CSL
  Limited - Out-Licensed Products/ Combination
  Treatment Modalities, 2014 15CSL Limited - Phase
  III, 2014 16CSL Limited - Phase II, 2014 17CSL
  Limited - Phase I, 2014 18CSL Limited -
  Preclinical, 2014 19CSL Limited - Discovery,
  2014 20

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
CSL Limited - Product Pipeline Review 2014

• CSL Limited - Pipeline by Therapeutic Class, 2014
  44CSL Limited - Pipeline by Target, 2014 47CSL
  Limited - Pipeline by Route of Administration,
  2014 48CSL Limited - Pipeline by Molecule Type,
  2014 49CSL Limited - Pipeline Products by
  Mechanism of Action, 2014 51CSL Limited - Recent
  Pipeline Updates, 2014 52CSL Limited - Dormant
  Developmental Projects,2014 57CSL Limited,
  Subsidiaries 64
• List of Figures
• CSL Limited - Pipeline by Top 10 Indication, 2014
  8CSL Limited - Pipeline by Stage of Development,
  2014 10CSL Limited - Monotherapy Products in
  Pipeline, 2014 11CSL Limited - Partnered
  Products in Pipeline, 2014 12CSL Limited -
  Out-Licensed Products in Pipeline, 2014 14CSL
  Limited - Pipeline by Top 10 Therapeutic Class,
  2014 43CSL Limited - Pipeline by Top 10 Target,
  2014 46
• CSL Limited - Pipeline by Top 10 Route of
  Administration, 2014 48
• CSL Limited - Pipeline by Top 10 Molecule Type,
  2014 49CSL Limited - Pipeline Products by Top 10
  Mechanism of Action, 2014 50

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.